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1 Introduction
According to the hyperglycemia-hyperinsulin-
ism hypothesis [12], fetal macrosomia in dia-
betic pregnancy results from a series of events
triggered by maternal hyperglycemia. Excessive
maternal glucose crossing the placenta causes
fetal hyperglycemia and thus overstimulates the
fetal pancreas. Fetal hyperinsulinemia, plus a
large supply of glucose substrate, greatly en-
hances protein, lipid and glycogen synthesis
and acts as a strong stimulant for growth of
fetal tissue. Over the years, this hypothesis has
been broadened to include other insulin-depen-
dent fuels as maternal stimuli of fetal macroso-
mia [4]. These are mainly free fatty acids (FFA)
and aminoacids, which are increased in the
maternal circulation due to inadequate insulin
release and are more available to the conceptus.
FFA are an addidional substrate for tissue
growth. Aminoacids, in addition to glucose,
favor maturation of beta-cells and stimulate
insulin release [6, 7, 8].
Prevention of fetal macrosomia, whether it is
due only to glucose or to other fuels too, de-
pends on correction of the maternal metabolic
derangement during pregnancy. The better ma-
ternal diabetes is compensated, the nearer to
normal fetal development will be and the lower
the risk of fetal overweight. In fact, in the last
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ten years a policy of tighter control of diabetes
has been in general adopted, and fetal macroso-
mia has declined. However, both the mean birth
weight and the percentage of oversized babies
are still high, much higher than normal, in all
case studies reported so far.
In a recent clinical study with a small number
of cases [18], the pregnant diabetics with strictly
regulated blood sugar levels gave birth to
growth retarded infants. The authors explained
this as follows: in pregnant diabetics, for some
still unknown cause, fetal development is in-
hibited in the early weeks of gestation. Later in
pregnancy, exaggerated activity of the glucose-
insulin system more than compensates for the
delayed initial growth, bringing about fetal ma-
crosomia. When there is strict metabolic con-
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trol of the maternal illness, the late macrosomic
stimulus is removed and the negative effect of
the delayed initial growth is allowed to manifest
itself, causing the fetus to be growth retarded
[18].
The aim of our study was to see whether or not
strict metabolic control of the diabetic mother
really does prevent fetal macrosomia and, if so,
whether this prevention results in normal or in
retarded fetal growth.
2 Material and methods
The birth weights of infants of the Milan series
of pregnant diabetics [14, 15] have been ana-
lyzed. Both pregnant women with gestational
diabetes (White's Class A) and those with clini-
cal diabetes (Classes B —F) had been treated
with the maximal tolerated dose (MTD) of in-
sulin. A detailed description of this therapeutic
regimen and the perinatal results have already
been published [14, 15].
The population consisted of 484 infants with
53 cases excluded because there were factors in
addition to maternal diabetes that may have
influenced fetal development (toxemia, conge-
nital malformations, etc.). The remaining 431
infants were distributed into groups according
to the severity of maternal diabetes: 217, gesta-
tional diabetes (Class A); 123, clinical diabetes
without vascular complications (Classes B and
C); 91, clinical diabetes with vascular complica-
tions (Classes D, E and F). Infants of Class E
were also considered separately. They were
born to mothers with gestational or clinical
diabetes and vascular pathology affecting only
the pelvic vessels.
2.1 Comparison with the birth weights of con-
trol newborns
The control group consisted of newborns whose
weights are generally assumed to be representa-
tive of our region (Northern Italy) [5]. This
series was matched for sex and gestational age
to each of the diabetic groups with which it
was being compared. The averages (table I) and
the centile distributions (figure 1) of the birth
weights were compared. The data were ana-
lyzed with the Student t-test and the Kolmogor-
ov-Smirnov test. Data for centile distributions
are plotted on probability paper (figure 1).
2.2 Comparison with the birth weights of in-
fants born in previous pregnancies to the multi-
parae in the case study
The multiparae (para II, 60; para III, 21) in-
cluded in the analyses met the following crite-
ria:
— delivery time in the present pregnancy
5= 36th week;
— in the present pregnancy, maternal diabetes
controlled with MTD insulin within the
30th week;
Table I. Birth weights of infants of diabetic mothers and control infants.
Infants of diabetic mothers Control newborns
White's
Classes
A
B,C
D,E,F
E
All Classes
Number
of infants
217
123
91
41
431
Weight (g)
X ± S D
3125 + 471
3209 ± 566
2925 ± 596
2935 + 507
3106 + 537
- 46
+ 46
-177
-195
- 50
Number
of infants
8166
7902
7964
6089
8308
Weight (g)
X + SD
3171 + 472
3163 ± 486
3102 + 519
3130 + 490
3156 ± 485
P
NS
NS
<0.01
<0.05
<0.05
p: Student t-test
NS: Not statistically significant
Δ: Difference in weight (in g) between infants of diabetic mother and normals
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Figure 1. Comparison of birth weight centiles between infants of diabetics and control newborns (Kolmogorov-
Smirnov test).
— delivery during the last month of gestation
in previous pregnancies;
— no treatment with MTD insulin in the pre-
vious pregnancies;
— previous pregnancies and delivery not fol-
lowed in our Center.
The mean birth weights in the last pregnancy
were compared with the mean birth weights in
the previous pregnancies, namely the first in
para II and the second in para III (t-test for
paired data) (table II). The pairs of siblings of
the two pregnancies were also compared and
Table Π. Multiparae (para II, III) pregnant diabetics: birth weight of infants in successive pregnancies.
Withe's
Classes
A
B,C
D,E,F
A
B,C
Number
of infants
30
20
10
10
11
Weight of infants
X + SD
1st Δ
3835 + 534
4033 + 648
3345 + 641
3520 ± 496 +
3886 + 548 +
(g)
[g)
620
696
480
200 (NS)°
197(NS)°
2nd A(g)
3215 + 324
3337 + 349
2865 + 406
3740 + 615 -539
4083 + 511 -874
3rd
3210 + 266
3209 + 255
Gestational
age (weeks)
X + SD
38.9 + 0.9
39.0 + 1.2
39.2 ± 1.1
39.3 + 1.2
39.2 ±1.9
°: t-test for paired data
NS: Not statistically significant
In the boxes: Maternal diabetes compensated with insulin MTD
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graphs were constructed of the weight differen-
ces between the second and the first versus the
weight of the first sibling (figures 2 and 3). The
regression line was calculated and the F-test
used for statistical analyses. For para III the
birth weights of infants born from the first
and the second pregnancies were also compared
(table II, figure 3). Since the patients were not
treated with MTD insulin in either of the two
pregnancies, we expected to find no differences
between the birth weights of these infants.
3 Results
3.1 Comparison with the birth weights of con-
trol newborns
As shown in table I, the mean birth weight of
the infants of Class A was 46 g less than that
for the controls, while the mean birth weight
of infants of Classes B and C was 46 g more,
neither difference being statistically significant.
The mean birth weight of infants of Classes D,
E and F was 177 g less than in the control
A kg. classes B and C n =20
+2-
A kg. class A n =30
+ 2-
- 1 -
- 2 -
- 1 -
- 2-
204//—·-
y r 2367-0.7594 Χ
ρ < 0.001
y = 2779 -0.8863 Χ
p<CX001
classes D, E and F n = 1 O
-2 -
Figure 2. Comparison of the birth weight of infants born to para II diabetic women. MTD insulin administered
only in the second pregnancy. Comparison of weights of the two siblings. On the horizontal axis, the weight of
the 1st sibling, on the vertical axis the difference in weight between the two siblings (2nd minus 1st). F-test.
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group (p < 0.01) and that of infants of Class
E was 195 g less (p < 0.05). The birth weight
of all infants was 50 g less than in the control
group and the difference was statistically sig-
nificant (p < 0.05).
More detailed information is obtained from
the comparison of the centiles of the infants'
weights (figure 1). There was a small difference
between the centiles of weights of all the infants
studied and those of the controls. The two
plots of centile distributions are close, but the
difference is significant (p < 0.01). The weight
differences fluctuate around 70 g (2%) along
the plots. When comparing Class A and Classes
B and C with the controls, the differences be-
tween the lines of centiles are slight (Class A)
(p < 0.01) or almost non-existent (Classes B
and C) (p > 0.05). When Class A is compared
with the controls, the difference in weight in-
A kg. class A n =10
h2
-| 2nd .nd 3rd
Δ kg. classes A, B and C n= 21
V« and 2nd
- 1 -
- 2-
y r 3162-0.9895X
p< O.O01
B
2 ,3
o4y/—· *-
- i -
- 2
4 ' ·5
A kg. classes Β a nd C n = 11
+ 2 -
 9nd2"dand 3
- 2 -
Figure 3. Comparison of the birth weight of infants born to para III diabetic women. MTD insulin administered
only in the third pregnancy.
A) Comparison of weights between the 1st and the 2nd siblings. Horizontal and vertical axis as in figure 2.
B, C) Comparison of weights between the 2nd and the 3rd siblings. On the horizontal axis, the weight of the 2nd
siblings, on the vertical axis the difference in weight between the two siblings (3rd minus 2nd). F-test.
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creases from 7 g (0.3%) to 87 (2%), going from
centiles 12.5 to 87.5. The weight difference be-
tween Classes B and C and controls is only a
few grams, reaching a maximum of 1%. There
is marked difference between the centiles of
weight for infants in Classes D, E and F and
those in the control group. In fact, the two
plots of centile distribution are well separated
(p < 0.01) and the weights of Classes D, E
and F are much lower all along the line. The
difference increases from the higher to the lower
centiles and remains around 220 — 250 g below
the 50th centile. There is a great difference
between Class E and the controls (p < 0.05).
3.2 Comparison with the birth weights of the
infants born in previous pregnancies to multipa-
rae in the case study
Any differences there were between the birth
weights in the present and the previous preg-
nancy may have been due not only to the strict
control of maternal diabetes in the present preg-
nancy, but also to differences between the
groups in sex and gestational age of the fetus
and maternal parity. However, the groups of
infants compared were homogeneous in terms
of sex distribution. Differences of sex between
one sibling and another, e. g. 1st male sibling
and 2nd female sibling, were counterbalanced
by differences of sex in the opposite direction,
i. e. 1st female and 2nd male. The other two
variables should have had positive effects, i. e.
favoring a higher birth weight of the infant of
the present pregnancy. In fact, we waited for
spontaneous labor (mean gestational age 39
week in every Class, table II), while delivery
had probably been induced in the preceding
pregnancy, which is common practice in dia-
betics, except for those of Class A. As regards
the influence of parity, the birth weight tends
to increase in subsequent pregnancies after the
first, and the present pregnancy of our multipa-
rae was, obviously, the latest one. Accordingly,
a lower birthweight of the last infant than of
the preceding would not only be attributable
to the strict control of maternal diabetes, but
even more significant.
In the para II of every Class, the mean birth
weight fell from the 1st to the 2nd pregnancy
(table II). The mean birth weights of the first
infants in Class A (3835 g) and Classes B and
C (4033 g) were higher than expected at 40
weeks', whereas, the mean birth weights in the
second (3215 g and 3337 g) resembled those of
normal newborns at 38 — 39 weeks. In diabetics
with vascular complications (Classes D, E and
F), the mean birth weight of the first infants
was similar to that of normal newborns, but
the mean birth weight of the second (2865 g)
was lower than expected at 38 — 39 weeks.
For the para III of Class A and Classes B and
C (table II), the mean birth weights were higher
than expected in the first infants (3520 g and
3886 g) and still high in the second pregnancy
(mothers not controlled with MTD insulin).
The weight reduction in the third infants
(mothers now compensated during pregnancy
with MTD insulin) was similar to that observed
in the para II.
As shown in figures 2 and 3 (B and C), the
weight reduction in infants whose mothers were
treated with the MTD insulin is directly propor-
tional to the birth weight of the preceding sib-
ling. The correlation is statistically significant
for every comparison. On the contrary, no cor-
relation could be observed when maternal dia-
betes was not strictly controlled. In fact, in
the second pregnancy of para III the tendency
toward overweight infants observed in the pre-
ceding pregnancy was confirmed and even
worsened (figure 3, A). From the graphs we can
observe that there is an end-point for weight
reduction in the latest sibling (maternal diabetes
strictly compensated), represented by the inter-
cept of the regression line on the horizontal
line. In fact, at this point the regression line,
running from right to left, enters the quadrant
in which the weight difference has a positive
sign, i. e. the weight of the latest sibling, instead
of being less, increases. At this intercept, in
pregnant diabetics without vascular complica-
tions the birth weights were similar to those of
control newborns of the same gestational age
(para II: Class A 3136 g, B and C 3117 g; para
III: Class A 3195 g, B and C 3110 g). On the
J. Perinat. Med. 15 (1987)
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contrary, in the para II with vascular complica-
tions the end-point for the weight reduction of
the latest sibling is a weight (2742 g) which is
lower than that of control newborns.
4 Comment
The results of this study clearly demonstrate
that fetal macrosomia can be prevented in
pregnant diabetic women. In fact, except for
infants of pregnant diabetics with vascular
complications, there was no significant differ-
ence between the averages and the centile distri-
butions of weights of controls and infants of
diabetics mothers (table I, figure 1). Our results
do not indicate that there is any risk of fetal
growth retardation as a consequence of the
compensation of maternal diabetes itself [18]. It
must be emphasized that our pregnant diabetics
were those most likely to give birth to growth-
retarded infants, since the dose of insulin they
received in pregnancy was the maximum toler-
ated. It is particularly noticeable for the multi-
parae that for the birth weight decrease in the
latest infants, as compared with the birth
weights of the preceding siblings (figures 2 and
3), there is a weight-limit under which the
weight decrease due to maternal metabolic
compensation does not go, this limit corre-
sponds to the normal birth weight for infants
of mothers without vascular complications.
As shown by the high incidence of fetal macro-
somia in patients with gestational diabetes, even
a minimal disturbance of fuel metabolism in
the mother is sufficient to cause an excess of
substrate to the fetus demonstrating, that nor-
mal fetal growth requires excellent control of
diabetes in pregnancy. In our case study this
was secured throughout pregnancy by adminis-
tration of the MTD of insulin. In fact, maternal
blood glucose was normalized, even though this
is not the specific purpose of this therapeutic
regimen [16]. It is noticeable that in multiparae
(table II) the birth weights of the infants in the
latest pregnancy were drastically smaller than
the birth weights of the infants in their previous
pregnancies (no MTD insulin). Moreover, the
reduction was greater, the greater the birth
weight of the corresponding sibling in the pre-
vious pregnancy (figures 2 and 3). This suggests
that the control of the weight increase that
can be obtained by compensation of maternal
diabetes is proportional to the risk of fetal
macrosomia.
All the studies published have shown that the
high incidence of large babies in gestational
diabetic women is not significantly decreased
when these patients are treated only by diet.
Even though their metabolic abnormality is
slight, its correction requires insulin therapy,
and we report here for the first time the norma-
lization of the birth weight of the infants of
gestational diabetic mothers (table I, figure 1).
Substitution of a clinical index for blood glu-
cose in the regulation of insulin dosage makes
the scheme of insulin administration at the
MTD particularly suitable for the treatment of
these patients.
In our population the only tendency to under-
sized babies was seen in diabetic pregnancies
with vascular complications (table I, figure 1).
This could have been anticipated since placental
blood flow, on which the access of substrates
to the fetus depends, is greatly impaired in
these patients. In this study, we saw that even
vascular damage limited to the pelvic vessels
(Class E) could greatly retard fetal growth
(table I, figure 1). This risk has not been re-
marked upon in the literature, because pelvic
vascular pathology is usually disregarded and
the patients remain undifferentiated among
pregnant diabetics of Classes A —C. Their fre-
quency seems to be high. If, in the present
study, we eliminate those infants in Classes
A—C whose mothers did not have pelvic vessel
examinations and redistribute Class E infants
into these Classes, the incidence of these infants
in Class A was 17% and in Classes B and C
12%.
It has been shown that in pregnant diabetics
there is no correlation between infant birth
weight and maternal blood glucose level [9,
11] and, in addition, that infants of diabetic
mothers, even though oversized for gestational
age, are not as large as they should be according
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to their hyperinsulinism [13]. This would imply
that fetal macrosomia cannot be due only to
maternal hyperglycemia and fetal hyperinsulin-
ism and that it could not be prevented only by
strict control of maternal diabetes. We believe
that the lack of correlation might be explained
by the results of recent animal studies [3]. It
has been shown that direct fetal insulin infusion
is accompanied by an increase in umbilical glu-
cose uptake, a decrease in fetal plasma glucose
concentration and a progressive decline in fetal
blood oxygen content. Up to now, the data
obtained in these studies has been used to ex-
plain sudden fetal death in diabetics during the
last month of pregnancy [1, 3]. Nevertheless, it
seems reasonable to believe that these episodes
of fetal hypoxia could vary in degree and dura-
tion and not always result in fetal death. During
these episodes, the fetus needs a marked
increase in the glycolysis rate, since the amount
of energy released during the conversion of
glucose to lactic acid is only a fraction of that
released in its complete oxidation to carbon
dioxide and water [17]. Accordingly, the hy-
poxic fetus would have to metabolize much
more glucose to produce the same amount of
energy and the burning of some of the excess
glucose transferred to the fetus from the dia-
betic mother could slow down fetal overgrowth.
As a result, in non-controlled diabetic preg-
nancy the birth weight would not correlate with
the maternal blood sugar level and, even though
it is high for gestational age, it will always be
lower than expected from the degree of fetal
hyperinsulinism.
There are many indirect proofs of fetal hypoxia
in diabetic pregnancy [10, 19, 20]. However,
direct evidence has been obtained only by
BERGLUND and ZETTERSTRÖM [2], who have
found the oxygen content in the umbilical cord
to be below normal limits in infants of diabetics
born by cesarean section. If future studies con-
firm that fetal hyperinsulinism causes hypoxia
as it does in experimental animals, this would
be a further reason for strictly controlling ma-
ternal diabetes and all aspects of fetal over-
growth, including those which seem at present
to be inconsistent with the hyperglycemia-hy-
perinsulinism theory, will be explained without
invoking any mechanism beyond that encom-
passed by the theory itself.
Summary
In this study the birth weights of 431 infants of diabetic
mothers of the Milan series [14,15] have been compared
with the birth weights of infants of a control group [5].
The averages and the centile distributions of weights of
infants of gestational diabetic mothers (Class A) and of
diabetic mothers without vascular complications
(Classes B and C) did not differ substantially from those
of control newborns (table I, figure 1). This confirms
the clinical indication, based on the hyperglycemia-hy-
perinsulinism theory [12] that fetal macrosomia can be
prevented provided maternal metabolism is strictly con-
trolled. In this series insulin was administered at the
maximal tolerated dose (MTD), a therapeutic regimen
that provides excellent metabolic control of the mother
[14, 15, 16]. In multiparae, the birth weights of the
infants of the latest pregnancy were drastically lower
than the birth weights of the infants in their previous
pregnancies (without MTD insulin) (table II). Our re-
sults do not confirm the recent hypothesis [18] that
pregnant diabetics with strict metabolic control during
pregnancy generally give birth to growth retarded in-
fants. The MTD of insulin has also been administered
to gestational diabetic mothers, and fetal macrosomia
was prevented (table I, figure 1). This confirms the
opinion of those who believe that a diet-regimen must
be accompanied by insulin administration to correct the
slight metabolic abnormality of these patients. As would
be expected because of placental insufficiency, infants
of patients with vascular complications, including those
who have only calcifications of the pelvic vessels (White'
Class E), were growth retarded (table I, figure 1). The
risk of fetal growth retardation in Class E has not been
remarked upon in the literature, since pathology of
pelvic vessels is usually disregarded and the patients
remain undifferentiated among Classes A —C. The pos-
sibility to prevent fetal macrosomia with a strict control
of maternal diabetes has been questioned because of the
lack of correlation between fetal macrosomia and the
degree of maternal hyperglycemia [9, 11] and of fetal
hyperinsulinism [13]. We postulate that, if fetal hyperin-
sulinism causes hypoxia, as it does in experimental ani-
mals [3], the lack of correlation may be due to the fetal
hyperinsulinism itself.
Keywords: Diabetes mellitus in pregnancy, fetal macrosomia, gestational diabetes, hyperglycemia-hyperinsulinism
theory, maximal tolerated dose of insulin.
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Zusammenfassung
Makrosomie bei Neugeborenen diabetischer Mütter —
Ursachen und Prävention
In der vorliegenden Studie werden die Geburtsgewichte
von 431 Kindern von Diabetikerinnen aus der Mailänder
Untersuchungsreihe [14,15] verglichen mit den Geburts-
gewichten von Kindern einer Kontrollgruppe [5]. Die
Mittelwerte und die Perzentilenverteilung der kindlichen
Geburtsgewichte bei Gestationsdiabetes (Klasse A) und
mütterlichem Diabetes ohne vaskuläre Komplikationen
(Klasse B und C) unterschieden sich nicht wesentlich
von denen der Kontrollgruppe (Tabelle I, Abb. 1). Basie-
rend auf der Hyperglykämie-Hyperinsulinismus-Theorie
[12] wird die klinische Vorstellung, daß bei strenger
Stoffwechselführung eine fetale Makrosomie vermieden
werden kann, bestätigt. Die Patientinnen erhielten Insu-
lin bis zur maximal tolerierten Dosis (MTD), und unter
dieser Therapie war die Stoffwechsellage optimal [14,
15,16]. Bei Mehrgebärenden war das kindliche Geburts-
gewicht nach Insulingabe in der Schwangerschaft erheb-
lich niedriger als die Geburtsgewichte nach vorangegan-
genen Schwangerschaften ohne Therapie (Tabelle II).
Unsere Ergebnisse bestätigen nicht die kürzlich aufge-
stellte Hypothese [18], nach der schwangere Diabetike-
rinnen mit strenger Stoffwechselführung generell wachs-
tumsretardierte Kinder zur Welt bringen. Auch Frauen
mit Gestationsdiabetes wurden mit Insulin bis zur MTD
therapiert; eine fetale Makrosomie wurde verhindert
(Tabelle I, Abb. 1). Das unterstützt die Auffassung, daß
bei diesen Frauen zusätzlich zur Diät Insulin verabreicht
werden sollte, um die geringfügigen metabolischen Ab-
weichungen zu korrigieren. Wie erwartet, waren Kinder
von Patientinnen mit vaskulären Komplikationen, auch
wenn es sich nur um Kalziflzierungen der pelvinen Ge-
fäße handelte (Klasse E nach dem White-Schema), we-
gen der plazentaren Insuffizienz wachstumsretardiert
(Tabelle I, Abb. 1). Diesem Phänomen wird in der Litera-
tur keine Aufmerksamkeit gewidmet, da die Pathologie
der pelvinen Gefäße unberücksichtigt bleibt und eine
Zuordnung der Patientinnen zu den Klassen A bis C
nicht stattfindet. Die Möglichkeit, eine fetale Makroso-
mie durch strenge Stoffwechselführung der Mutter zu
vermeiden, wurde in Frage gestellt, weil zwischen der
fetalen Makrosomie und der Ausprägung der materna-
len Hyperglykämie und des fetalen Hyperinsulinismus
keine Korrelation vorliegt [9, 11, 13]. Wir postulieren:
Wenn, wie im Tierexperiment nachgewiesen [3], ein feta-
ler Hyperinsulinismus eine Hypoxie verursacht, kann
diese fehlende Korrelation auf den fetalen Hyperinsuli-
nismus zurückgeführt werden.
Schlüsselwörter: Diabetes mellitus und Schwangerschaft, fetale Makrosomie, Gestationsdiabetes, Hyperglykämie-
Hyperinsulinismus-Theorie, maximal tolerierte Insulindosis.
Resume
Enfants macrosomes de meres diabetiques: causes et pre-
vention
Dans cette etude on a compare les poids de naissance
de 431 enfants de meres diabetiques de la serie de Milan
[14, 15] aux poids de naissance d'un groupe controle [5].
Les moyennes et les distributions en percentiles des poids
des enfants des meres avec un diabete gestationnel (classe
A) et des meres diabetiques sans complication vasculaire
(classe B et C) ne sont pas tres differents de ceux des
nouveaux-nes controles (tableau I, figure 1). Celä
confirme Findication dinique, fondee sur la theorie
hyperglycemie-hyperinsulinemie [12] qui estime que
peut eviter la macrosomie foetale en equilibrant de facon
stricte le metabolisme maternel. Dans cette serie Finsu-
line etait injectee ä la dose maximale toleree (MTD),
attitude therapeutique qui assure un controle metaboli-
que excellent chez les meres [14, 15, 16]. Chez les multi-
pares, les poids de naissance des enfants lors de la
derniere grossesse etaient extremement inferieurs aux
poids de naissance des enfants lors des grossesses prece-
dentes (sans insuline a MTD) (tableau II). Nos resultats
ne confirment pas Fhypothese recente [18] que les diabe-
tiques enceintes ayant un controle metabolique strict au
cours de la grossesse donnent naissance en regie generate
ä des enfants hypotrophiques. On a egalement injecte
Finsuline ä MTD ä des meres avec un diabete gestation-
nel et la macrosomie foetale a etc evitee (tableau I, figure
1). Celä confirme l'opinion de ceux qui croient qu'un
regime doit accompagner Finjection d'insuline pour cor-
riger les anomalies metaboliques legeres de ces patientes.
Comme on s'y attendait, en raison de l'insuffisance
placentaire, les enfants des patientes presentant des com-
plications vasculaires, y compris celles qui ont des calcifi-
cations des vaisseaux pelviens (classe E de White), ont
eu un retard de croissance (tableau I, figure 1). Le risque
de retard de croissance intra-uterin dans la classe E n'a
pas etc remarque dans la litterature, car, habituellement,
on ne tient pas compte de la pathologic des vaisseaux
pelviens et les patientes ne sont pas differentiees des
classes A —C. La possibilite de prevenir la macrosomie
foetale par un controle strict du diabete maternel est
mise en question, en raison du manque de correlation
[9,11,13] entre la macrosomie foetale et le degre d'hyper-
glycemie maternelle et Fhyperinsulinisme foetal. Notre
these: lorsque, Fhyperinsulinisme foetal entraine une hy-
poxie, comme cela se produit en experimentation ani-
male [3], le manque de correlation peut etre, lui-meme,
secondaire ä Fhyperinsulinisme foetal.
Mots-cles: Diabete gestationnel, diabete sucre au cours de la grossesse, dose maximale toleree d'insuline, macroso-
mie foetale, theorie hyperglycemie-hyperinsulinisme.
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